LY96 and monocytic leukemia: The compounds 5a–l were subjected to the in vitro evaluation of their antiproliferative (cytotoxic) activity using the THP1-XBlueTM-MD2-CD14 cell line derived from the human monocytic leukemia THP-1 cell line [39].